IBDEI13S ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19667,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19667,1,2,0)
 ;;=2^J0885
 ;;^UTILITY(U,$J,358.3,19667,1,3,0)
 ;;=3^EPOGEN INJ, NON-ESRD 1000 UNITS
 ;;^UTILITY(U,$J,358.3,19668,0)
 ;;=J0881^^111^1174^4^^^^1
 ;;^UTILITY(U,$J,358.3,19668,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19668,1,2,0)
 ;;=2^J0881
 ;;^UTILITY(U,$J,358.3,19668,1,3,0)
 ;;=3^ARANESP (NON-ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,19669,0)
 ;;=J0882^^111^1174^3^^^^1
 ;;^UTILITY(U,$J,358.3,19669,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19669,1,2,0)
 ;;=2^J0882
 ;;^UTILITY(U,$J,358.3,19669,1,3,0)
 ;;=3^ARANESP (ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,19670,0)
 ;;=J1826^^111^1174^27^^^^1
 ;;^UTILITY(U,$J,358.3,19670,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19670,1,2,0)
 ;;=2^J1826
 ;;^UTILITY(U,$J,358.3,19670,1,3,0)
 ;;=3^INTERFERON BETA-1A 30mcg
 ;;^UTILITY(U,$J,358.3,19671,0)
 ;;=J9217^^111^1174^35^^^^1
 ;;^UTILITY(U,$J,358.3,19671,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19671,1,2,0)
 ;;=2^J9217
 ;;^UTILITY(U,$J,358.3,19671,1,3,0)
 ;;=3^LEUPROLIDE INJ 7.5MG
 ;;^UTILITY(U,$J,358.3,19672,0)
 ;;=J9218^^111^1174^33^^^^1
 ;;^UTILITY(U,$J,358.3,19672,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19672,1,2,0)
 ;;=2^J9218
 ;;^UTILITY(U,$J,358.3,19672,1,3,0)
 ;;=3^LEUPROLIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,19673,0)
 ;;=J1950^^111^1174^34^^^^1
 ;;^UTILITY(U,$J,358.3,19673,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19673,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,19673,1,3,0)
 ;;=3^LEUPROLIDE INJ 3.75MG
 ;;^UTILITY(U,$J,358.3,19674,0)
 ;;=J9219^^111^1174^32^^^^1
 ;;^UTILITY(U,$J,358.3,19674,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19674,1,2,0)
 ;;=2^J9219
 ;;^UTILITY(U,$J,358.3,19674,1,3,0)
 ;;=3^LEUPROLIDE IMPLANT 65MG
 ;;^UTILITY(U,$J,358.3,19675,0)
 ;;=J0696^^111^1174^59^^^^1
 ;;^UTILITY(U,$J,358.3,19675,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19675,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,19675,1,3,0)
 ;;=3^ROCEPHIN INJ-250MG
 ;;^UTILITY(U,$J,358.3,19676,0)
 ;;=J0696^^111^1174^58^^^^4
 ;;^UTILITY(U,$J,358.3,19676,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19676,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,19676,1,3,0)
 ;;=3^ROCEPHIN INJ-1GM
 ;;^UTILITY(U,$J,358.3,19677,0)
 ;;=J1030^^111^1174^39^^^^1
 ;;^UTILITY(U,$J,358.3,19677,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19677,1,2,0)
 ;;=2^J1030
 ;;^UTILITY(U,$J,358.3,19677,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 40MG
 ;;^UTILITY(U,$J,358.3,19678,0)
 ;;=J1020^^111^1174^38^^^^1
 ;;^UTILITY(U,$J,358.3,19678,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19678,1,2,0)
 ;;=2^J1020
 ;;^UTILITY(U,$J,358.3,19678,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 20MG
 ;;^UTILITY(U,$J,358.3,19679,0)
 ;;=J1040^^111^1174^40^^^^1
 ;;^UTILITY(U,$J,358.3,19679,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19679,1,2,0)
 ;;=2^J1040
 ;;^UTILITY(U,$J,358.3,19679,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 80MG
 ;;^UTILITY(U,$J,358.3,19680,0)
 ;;=J2920^^111^1174^42^^^^1
 ;;^UTILITY(U,$J,358.3,19680,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19680,1,2,0)
 ;;=2^J2920
 ;;^UTILITY(U,$J,358.3,19680,1,3,0)
 ;;=3^METHYLPREDNISOLONE SOD IV 40MG
 ;;^UTILITY(U,$J,358.3,19681,0)
 ;;=J2930^^111^1174^41^^^^1
 ;;^UTILITY(U,$J,358.3,19681,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19681,1,2,0)
 ;;=2^J2930
 ;;^UTILITY(U,$J,358.3,19681,1,3,0)
 ;;=3^METHYLPREDNISOLONE SOD IV 125MG
 ;;^UTILITY(U,$J,358.3,19682,0)
 ;;=J1756^^111^1174^29^^^^1
 ;;^UTILITY(U,$J,358.3,19682,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19682,1,2,0)
 ;;=2^J1756
 ;;^UTILITY(U,$J,358.3,19682,1,3,0)
 ;;=3^IRON SUCROSE INJ 1MG
 ;;^UTILITY(U,$J,358.3,19683,0)
 ;;=J1745^^111^1174^56^^^^1
